News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
260 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17904)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2885)
Day
2 (42)
5 (179)
6 (279)
7 (219)
8 (266)
9 (160)
11 (1)
12 (260)
13 (182)
14 (148)
15 (119)
16 (95)
19 (84)
20 (183)
21 (152)
22 (149)
23 (92)
24 (2)
26 (148)
27 (157)
28 (163)
29 (199)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
5
6
7
8
9
11
12
13
14
15
16
19
20
21
22
23
24
26
27
28
29
30
Drug Development
Portola Pharmaceuticals, Inc. Initiates Phase 4 Study To Support Accelerated Approval Of Andexanet Alfa -- Its Breakthrough-Designated Factor Xa Inhibitor Antidote
January 12, 2015
·
9 min read
Biotech Bay
Altos Therapeutics Receives Second Issued Patent Covering Novel Dopamine D2/D3 Antagonists For The Treatment Of Gastrointestinal Diseases
January 12, 2015
·
2 min read
BioMidwest
Centene Corporation Announces Pricing Of Notes
January 12, 2015
·
3 min read
Hikma Pharmaceuticals To Launch Colchicine 0.6mg Capsules
January 12, 2015
·
1 min read
Deals
Oculus Innovative Sciences, Inc. Enters Into Agreement To Sell Ruthigen Shares For $5.5 Million In Event Of Ruthigen Merger
January 12, 2015
·
3 min read
Deals
QIAGEN N.V. Acquires Enzymatics Inc. Enzyme Solutions Unit, A Leading Enabler Of NGS Applications
January 12, 2015
·
7 min read
Deals
Aegerion Pharmaceuticals, Inc. Completes Acquisition Of MYALEPT®
January 12, 2015
·
8 min read
Business
Emergent BioSolutions Announces Preliminary 2014 Financial Results And Provides 2015 Financial Outlook
January 12, 2015
·
8 min read
Business
ORYZON Genomics Appoints Greg Weaver As Global Chief Financial Officer
January 12, 2015
·
3 min read
Business
AMAG Pharmaceuticals, Inc. Provides Business Update And 2015 Financial Guidance
January 12, 2015
·
17 min read
Previous
24 of 26
Next